Ampacet's AI system automatically corrects color variations in real time, improving quality and reducing waste in operations.

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

An analysis of CIRDC, dissecting the polymicrobial nature of the syndrome and outlining standards for diagnostic testing.

Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire ...

EFS Plastics calls for stronger policies and collaboration to boost post-consumer resin adoption amid low virgin plastic ...

The FDA has granted breakthrough therapy designation (BTD) to fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the ...

Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

Among adults with evidence of systemic mast cell activation, bone marrow samples allowed for detection of 13 additional ...

Disclaimer: Trastuzumab deruxtecan has not been approved by the FDA for the neoadjuvant or adjuvant setting for early-stage, ...

Earlier this year the Therapeutic Goods Administration (TGA) halted the sale of 21 sunscreen products in Australia following ...

Investigators evaluated whether the addition of carboplatin to neoadjuvant chemotherapy improved efficacy outcomes in patients with early-stage TNBC.